Alpa Laboratories Financials
NSE: ALPA | BSE: 532878
₹62.71
As on 04-Sep-2026 15:54IST
Market cap
₹134 Cr
Revenue (TTM)
₹111 Cr
P/E Ratio
30.5
P/B Ratio
0.7
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
110.63
|
112.45
|
108.74
|
92.96
|
112.27
|
97.55
|
|||||
|
Total Income
|
120.21
|
135.80
|
123.63
|
102.32
|
123.04
|
101.95
|
|||||
|
Total Expenditure
|
111.72
|
107.70
|
100.63
|
84.88
|
101.61
|
89.86
|
|||||
|
EBITDA
|
-1.09
|
4.75
|
8.11
|
8.07
|
10.66
|
7.70
|
|||||
|
Depreciation
|
2.26
|
2.20
|
1.95
|
1.33
|
1.66
|
1.23
|
|||||
|
EBIT
|
-3.35
|
2.55
|
6.15
|
6.75
|
9.00
|
6.47
|
|||||
|
Interest
|
0.32
|
0.23
|
0.36
|
0.22
|
0.22
|
0.08
|
|||||
|
Other Income
|
9.58
|
23.35
|
14.89
|
9.37
|
10.78
|
4.40
|
|||||
|
Exceptional Items
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
5.91
|
25.67
|
20.68
|
15.89
|
19.56
|
10.79
|
|||||
|
Provision for Tax
|
1.53
|
6.16
|
3.91
|
3.31
|
5.47
|
3.54
|
|||||
|
Profit after Tax
|
4.38
|
19.50
|
16.78
|
12.58
|
14.09
|
7.25
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
4.38
|
19.50
|
16.78
|
12.58
|
14.09
|
7.25
|
Liabilities (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
186.28
|
171.43
|
151.91
|
134.58
|
121.73
|
107.64
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
3.34
|
4.49
|
2.40
|
3.06
|
4.70
|
0.23
|
|||||
|
Current Liabilities
|
52.53
|
46.70
|
28.07
|
29.63
|
28.81
|
32.50
|
|||||
|
Total Liabilities
|
242.15
|
222.63
|
182.37
|
167.27
|
155.24
|
140.37
|
Assets (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
26.78
|
30.14
|
21.39
|
18.14
|
17.23
|
19.28
|
|||||
|
Current Assets
|
210.90
|
192.49
|
160.98
|
149.13
|
138.01
|
121.09
|
|||||
|
Total Assets
|
242.15
|
222.63
|
182.37
|
167.27
|
155.24
|
140.37
|
|||||
|
Total Debt*
|
--
|
0.03
|
5.25
|
2.30
|
5.85
|
0.19
|
|||||
|
Net Current Assets
|
158.37
|
145.79
|
132.92
|
119.50
|
109.20
|
88.59
|
|||||
|
Contingent Liabilities
|
--
|
6.65
|
3.61
|
3.18
|
5.21
|
5.21
|
Cashflow (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
18.32
|
3.65
|
8.90
|
9.94
|
-1.70
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-12.36
|
-13.34
|
2.13
|
-15.61
|
5.86
|
|||||
|
Cash from Financing Activities
|
--
|
-5.44
|
2.58
|
-3.79
|
5.44
|
0.18
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
0.51
|
-7.10
|
7.24
|
-0.23
|
4.34
|
Financials Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
2.08
|
9.27
|
7.97
|
5.98
|
6.70
|
3.44
|
|||||
|
Cash EPS (₹)
|
2.08
|
10.32
|
8.90
|
6.61
|
7.48
|
4.03
|
|||||
|
Adjusted Book Value (₹)
|
89.00
|
81.48
|
72.20
|
63.96
|
57.86
|
51.16
|
|||||
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share (₹)
|
--
|
8.71
|
1.73
|
4.23
|
4.72
|
-0.81
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
10.75
|
3.94
|
5.70
|
7.13
|
-2.42
|
Profitability Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
15.76
|
14.31
|
12.19
|
16.81
|
10.42
|
|||||
|
ROE (%)
|
2.37
|
12.06
|
11.71
|
9.82
|
12.29
|
6.97
|
|||||
|
ROA (%)
|
1.88
|
9.63
|
9.60
|
7.80
|
9.53
|
5.56
|
|||||
|
EBIT Margin (%)
|
-3.03
|
2.27
|
5.66
|
7.26
|
8.02
|
6.63
|
|||||
|
Net Margin (%)
|
3.64
|
14.36
|
13.57
|
12.30
|
11.45
|
7.11
|
|||||
|
Cash Profit Margin (%)
|
--
|
19.30
|
17.23
|
14.97
|
14.03
|
8.69
|
Growth Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.46
|
3.41
|
16.98
|
-17.20
|
15.08
|
13.48
|
|||||
|
EBIT Growth (%)
|
-235.67
|
-58.53
|
-8.81
|
-25.08
|
39.21
|
3,281.18
|
|||||
|
Net Profit Growth (%)
|
-83.31
|
16.25
|
33.33
|
-10.71
|
94.45
|
291.02
|
|||||
|
EPS Growth (%)
|
-83.31
|
16.25
|
33.33
|
-10.71
|
94.45
|
291.00
|
|||||
|
Book Value Growth (%)
|
--
|
12.85
|
12.88
|
10.55
|
13.09
|
7.24
|
Valuation Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
30.51
|
11.23
|
10.46
|
8.99
|
10.38
|
10.50
|
|||||
|
Price / Book Value
|
0.71
|
1.28
|
1.16
|
0.84
|
1.20
|
0.71
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
15.70
|
7.72
|
7.79
|
6.11
|
7.02
|
5.44
|
|||||
|
Close Price (₹)
|
67.55
|
103.60
|
83.25
|
53.80
|
69.70
|
36.00
|
|||||
|
High Price (₹)
|
109.85
|
144.60
|
115.00
|
89.70
|
108.95
|
48.80
|
|||||
|
Low Price (₹)
|
46.00
|
69.90
|
50.60
|
47.35
|
36.00
|
13.55
|
|||||
|
Market Cap (₹ Cr)
|
133.57
|
219.08
|
175.50
|
113.15
|
146.23
|
76.06
|
Solvency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.00
|
0.03
|
0.02
|
0.05
|
0.00
|
|||||
|
Short term debt to equity ratio
|
--
|
0.00
|
0.03
|
--
|
0.02
|
--
|
|||||
|
Current Ratio
|
4.01
|
4.12
|
5.74
|
5.03
|
4.79
|
3.73
|
|||||
|
Quick Ratio
|
3.76
|
3.74
|
5.25
|
4.61
|
4.25
|
3.22
|
|||||
|
Interest Coverage
|
19.47
|
111.73
|
58.58
|
72.07
|
90.32
|
139.47
|
Operating Efficiency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
36.91
|
41.64
|
37.84
|
50.27
|
33.88
|
36.32
|
|||||
|
Asset Turnover
|
0.48
|
0.56
|
0.62
|
0.58
|
0.76
|
0.75
|
|||||
|
Receivable days
|
--
|
142.78
|
147.50
|
166.43
|
119.43
|
112.28
|
|||||
|
Inventory Days
|
--
|
50.81
|
44.15
|
55.18
|
52.06
|
54.46
|
|||||
|
Payable days
|
--
|
79.22
|
71.98
|
99.58
|
103.71
|
117.94
|
|||||
|
Cash Conversion Cycle
|
--
|
114.37
|
119.67
|
122.02
|
67.77
|
48.80
|